These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 660732)

  • 61. Accuracy of staging in A1 carcinoma of the prostate.
    Parfitt HE; Smith JA; Gliedman JB; Middleton RG
    Cancer; 1983 Jun; 51(12):2346-50. PubMed ID: 6850514
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A; Ohlmann CH
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Clinico-pathological study on prostatic cancer, stage A using step section technic].
    Yushita Y; Minami Y; Sakuragi T; Kusaba Y; Kanetake H; Shindo K; Saito Y; Hara T; Tasaki T
    Hinyokika Kiyo; 1987 Aug; 33(8):1185-92. PubMed ID: 3425518
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Staging lymphadenectomy should be an antecedent to treatment in localized prostatic carcinoma.
    Olsson CA
    Urology; 1985 Feb; 25(2 Suppl):4-6. PubMed ID: 3969765
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Radical prostatectomy in patients with incidental prostate carcinoma.
    Manseck A; Wirth M; Theiss M; Frohmüller H
    Urol Int; 1994; 53(4):196-208. PubMed ID: 7531896
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study.
    Kim IY; Modi PK; Sadimin E; Ha YS; Kim JH; Skarecky D; Cha DY; Wambi CO; Ou YC; Yuh B; Park S; Llukani E; Albala DM; Wilson T; Ahlering T; Badani K; Ahn H; Lee DI; May M; Kim WJ; Lee DH
    J Urol; 2013 Aug; 190(2):527-34. PubMed ID: 23485503
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
    Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
    J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Present status and questions on early prostatic cancer (stage A, B)].
    Oishi K; Arai Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Radical prostatectomy and adjuvant radioactive gold seed placement: results of treatment at 5 and 10 years for clinical stages A2, B1 and B2 cancer of the prostate.
    Kwon ED; Loening SA; Hawtrey CE
    J Urol; 1991 Mar; 145(3):524-31. PubMed ID: 1997703
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expectant management of localized prostatic cancer.
    Whitmore WF; Warner JA; Thompson IM
    Cancer; 1991 Feb; 67(4):1091-6. PubMed ID: 1991257
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical significance of pelvic lymph node status in prostate cancer: review of 1690 cases.
    Maccio L; Barresi V; Domati F; Martorana E; Cesinaro AM; Migaldi M; Iachetta F; Ieni A; Bonetti LR
    Intern Emerg Med; 2016 Apr; 11(3):399-404. PubMed ID: 26875178
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prostatic adenocarcinoma: relationship of grade and local extent to the pattern of metastases.
    Barzell W; Bean MA; Hilaris BS; Whitmore WF
    J Urol; 1977 Aug; 118(2):278-82. PubMed ID: 894806
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Lymphogenic metastases in prostatic cancer--operative and histopathologic investigations ].
    Schubert J; Heidl G
    Arch Geschwulstforsch; 1982 May; 52(3):213-21. PubMed ID: 7125858
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Correlation between side of palpable tumor and side of pelvic lymph node metastasis in clinically localized prostate cancer.
    Harrison SH; Seale-Hawkins C; Schum CW; Dunn JK; Scardino PT
    Cancer; 1992 Feb; 69(3):750-4. PubMed ID: 1730125
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Prostatic cancer between 50 and 60. A more than 20-year-long retrospective study. Apropos of 65 case reports].
    Aubert J; Orget J; Bon D; Marroncle M
    Acta Urol Belg; 1993 Dec; 61(4):5-12. PubMed ID: 7507634
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup.
    Epstein JI; Paull G; Eggleston JC; Walsh PC
    J Urol; 1986 Oct; 136(4):837-9. PubMed ID: 3761442
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Incidental carcinoma of the prostate. How much sampling is adequate?
    Murphy WM; Dean PJ; Brasfield JA; Tatum L
    Am J Surg Pathol; 1986 Mar; 10(3):170-4. PubMed ID: 3513636
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pattern of care and follow-up of stages A1, B1 prostatic cancers from multicenter group, the National Prostatic Cancer Treatment Group (NPCTG).
    Murphy GP; Gaeta J; Priore R
    Urology; 1987 Mar; 29(3):258-61. PubMed ID: 3824720
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The contribution of subclinical cancer to Denver's high prostatic cancer incidence rate.
    Beckner M; Berg JW; Franz LW
    J Chronic Dis; 1985; 38(3):225-31. PubMed ID: 3988880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.